Fixed combinations of delapril plus indapamide vs fosinopril plus hydrochlorothiazide in mild to moderate essential hypertension-Reference-Cited by-同舟云学术

Fixed combinations of delapril plus indapamide vs fosinopril plus hydrochlorothiazide in mild to moderate essential hypertension

Published:2002-05 Issue:3 Volume:19 Page:129-137
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Therapy

Author:

Cremonesi G.,Cavalieri L.,Cikes I.,Dobovisek J.,Bacchelli S.,Esposti D. Degli,Costa F. V.,Borghi C.,Ambrosioni E.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF02850269.pdf

Reference25 articles.

1. Mancia G, Failla M, Grappiolo A, Giannattasio C. Present and future role of combination treatment in hypertension.J Cardiovasc Pharmacol. 1998;31(suppl 2):S431-S444.

2. Messerli FH. Combination therapy in hypertension.J Hum Hypertens. 1992;6(suppl 2):S19-S21.

3. Waeber B, Brunner HR. Combination antihypertensive therapy: does it have a role in rational therapy?Am J Hypertens. 1997;10:131S-137S.

4. Moser M, Black HR. The role of combination therapy in the treatment of hypertension.Am J Hypertens. 1998;11:73S-78S.

5. Kaplan N. Low dose combinations in the treatment of hypertension: theory and practice.J Hum Hypertens. 1999;13:707–710.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The current position of hydrochlorothiazide among thiazide and thiazide-like diuretics;Vnitřní lékařství;2018-01-01

2. Which thiazide to choose as add-on therapy for hypertension?;Integrated Blood Pressure Control;2014-07

3. Benefits of delapril in hypertensive patients along the cardiovascular continuum;Expert Review of Cardiovascular Therapy;2013-03

4. Efficacy and safety of delapril/indapamide compared to different ACE-inhibitor/hydrochlorothiazide combinations: a meta-analysis;International Journal of General Medicine;2012-08

5. Blood pressure responder rates versus goal rates: which metric matters?;Therapeutic Advances in Cardiovascular Disease;2009-01-26